During the past decade, Unidad de Investigacion Clinica Cardiometabolica de Occidente conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 9 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 8 clinical trials were completed. i.e. 266.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Unidad de Investigacion Clinica Cardiometabolica de Occidente" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Unidad de Investigacion Clinica Cardiometabolica de Occidente" are "Gastroparesis" (3 trials), "Diabetes Mellitus" (2 trials), "Heart Failure" (2 trials), "Type 1 Diabetes Mellitus" (2 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Unidad de Investigacion Clinica Cardiometabolica de Occidente" in a lesser frequency.

Most popular intervention types in "Unidad de Investigacion Clinica Cardiometabolica de Occidente" are "Drug" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Empagliflozin" (3 trials), "Insulin Degludec" (2 trials), "Insulin Glargine" (2 trials) and "Insulin Lispro" (2 trials). Other intervention names were less common.

The vast majority of trials in "Unidad de Investigacion Clinica Cardiometabolica de Occidente" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Unidad de Investigacion Clinica Cardiometabolica de Occidente". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Unidad de Investigacion Clinica Cardiometabolica de Occidente, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Unidad de Investigacion Clinica Cardiometabolica de Occidente, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".